Serum 25(OH)D as a Biomarker for Cognitive Impairment in Parkinson Disease
Researchers sought to assess the relationship between serum 25(OH)D levels and cognition in patients with Parkinson disease.
All articles by Jessica Nye, PhD
Suicidal Ideation Not Related With Psychological Pain After Receiving Ketamine
Data for this study were sourced from 4 active treatment arms of 4 randomized, controlled trials conducted by the National Institutes of Health in the United States between 2006 and 2018.
Substantial Reorganization of Structural Brain Networks Among Young Adults at High Risk for BD
This study recruited individuals aged 12-30 years who had first-degree relatives with BD I or II and those with no family history of mental illness.
ANN Model Predicts Post-MVD Pain Among Patients With Trigeminal Neuralgia
Using a constructed ANN model, researchers sought to predict the long-term outcomes of microvascular decompression surgery and the factors that influence prognosis in patients with trigeminal neuralgia.
Determinants of Pain, Disability, and QoL in Chronic Inflammatory Demyelinating Polyneuropathy
Pain of any type was a relevant factor for the sequelae of chronic inflammatory demyelinating polyneuropathy.
The Effect of Statins on Dementia Risk in Familial Hypercholesterolemia
Researchers sought to examine whether individuals with familial hypercholesterolemia are at a heightened risk for dementia and whether statin use is tied to dementia risk.
Sensory Phenotypes May Predict Pregabalin Response in Chronic Posttraumatic Neuropathic Pain
A secondary analysis sought to identify predictors of pregabalin response in those with chronic posttraumatic neuropathic pain.
Some Plasma Biomarkers for AD Misleading in Black Populations – A Conversation With Susan E. Schindler, MD, PhD
We spoke with Susan E. Schindler, MD, PhD, lead author of a study about the effect of race on the prediction of brain amyloidosis by plasma Aβ42/Aβ40, phosphorylated tau, and neurofilament light.
Ketamine Infusions Improve Symptoms of Depression and Pain
Patients with treatment-resistant major depressive disorder or bipolar disorder without psychotic symptoms received intravenous infusions of 0.5 mg/kg ketamine 3 times per week for 2 weeks.
Is Late-Onset Depression a Prodrome to Major Neurocognitive Disorder?
In a case-control study, researchers assessed the potential link between late-onset depression and the risk of developing major cognitive disorder.
- Loading...
Loading...
Next post in Neurocognitive Disorders
Loading... 
Loading...